Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study of SI-6603 in Patients With Lumbar Disc Herniation

ClinicalTrials.gov ID: NCT01941563

Public ClinicalTrials.gov record NCT01941563. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 2:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of SI-6603 (condoliase) in patients with lumbar disc herniation.

Study identification

NCT ID
NCT01941563
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Seikagaku Corporation
Industry
Enrollment
385 participants

Conditions and interventions

Eligibility (public fields only)

Age range
30 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2013 (Type not available)
Primary completion
Nov 2015 (Actual)
Completion
Aug 2017 (Actual)
Last update posted
Mar 23, 2023

2013 – 2017

United States locations

U.S. sites
32
U.S. states
16
U.S. cities
32
Facility City State ZIP Site status
Not listed Phoenix Arizona — —
Not listed Gold River California — —
Not listed Laguna Hills California — —
Not listed Los Gatos California — —
Not listed Murrieta California — —
Not listed Riverside California — —
Not listed Denver Colorado — —
Not listed Hialeah Florida — —
Not listed Jacksonville Florida — —
Not listed Merritt Island Florida — —
Not listed Miami Florida — —
Not listed Naples Florida — —
Not listed North Miami Beach Florida — —
Not listed Orlando Florida — —
Not listed Pinellas Park Florida — —
Not listed Sarasota Florida — —
Not listed St. Petersburg Florida — —
Not listed Sunrise Florida — —
Not listed Winter Park Florida — —
Not listed Marietta Georgia — —
Not listed Newnan Georgia — —
Not listed Bloomington Illinois — —
Not listed Carmel Indiana — —
Not listed Shreveport Louisiana — —
Not listed City of Saint Peters Missouri — —
Not listed Hartsdale New York — —
Not listed Eugene Oregon — —
Not listed State College Pennsylvania — —
Not listed Charleston South Carolina — —
Not listed Dallas Texas — —
Not listed Sandy City Utah — —
Not listed Edmonds Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01941563, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 23, 2023 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01941563 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →